Browse > Article

Intraperitoneal Cisplatin Chemotherapy in A Canine Ovarian Cancer with Peritoneal Metastasis  

Seo, Kyoung-Won (Seoul National University hospital for animals, the Research Institute of Veterinary Science)
Lee, Jong-Bok (Seoul National University hospital for animals, the Research Institute of Veterinary Science)
Hong, Su-Ji (Seoul National University hospital for animals, the Research Institute of Veterinary Science)
Oh, Ye-In (Seoul National University hospital for animals, the Research Institute of Veterinary Science)
Lee, Su-Hyung (Department of pathology, College of Veterinary Medicine, Seoul National University)
Youn, Hwa-Young (Seoul National University hospital for animals, the Research Institute of Veterinary Science)
Jang, Goo (Seoul National University hospital for animals, the Research Institute of Veterinary Science)
Publication Information
Journal of Veterinary Clinics / v.28, no.6, 2011 , pp. 598-602 More about this Journal
Abstract
A 4-year-old female Shih-tzu dog weighing 5.1 kg was referred with abdominal distension and diagnosed as cystic papillary adenocarcinoma with metastasis to serosal surface of abdomen by biopsy. Intraperitoneal chemotherapy with cisplatin (50 $mg/m^2$) diluted in normal saline (250 $ml/m^2$) was initiated following removal of ascites one month after ovariohysterectomy (OHE). Clinical response was great and had no side effects during the chemotherapy period (3 relapses, 33 months after diagnosis). However, pleural effusion occurred with ascites and renal failure at the end of treatment. Eleven treatments of cisplatin were performed during 35 months after diagnosis. Intraperitoneal cisplatin instillation has been effective to control malignant ascites and pleural effusion in ovarian cancers and could be a reasonable palliative treatment. This is the first case report describing intraperitoneal cisplatin chemotherapy in metastatic ovarian cyst papillary adenocarcinoma in Korea.
Keywords
chemotherapy; dog; malignant ascites; ovarian metastatic cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ozols RF. Counterpoint: Intraperitoneal chemotherapy: an investigational treatment in ovarian cancer. J Natl Compr Canc Netw 2004; 2: 555-560.   DOI
2 Patnaik AK, Greenlee PG. Canine ovarian neoplasms: a clinicopathologic study of 71 cases, including histology of 12 granulosa cell tumors. Vet Pathol 1987; 24: 509-514.   DOI
3 Rothenberg ML, Liu PY, Braly PS, Wilczynski SP, Hannigan EV, Wadler S, et al. Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial. J Clin Oncol 2003; 21: 1313-1319.   DOI   ScienceOn
4 Sforna M, Brachelente C, Lepri E, Mechelli L. Canine ovarian tumours: a retrospective study of 49 cases. Vet Res Commun 2003; 27 Suppl 1: 359-361.
5 Fujiwara K, Markman M, Morgan M, Coleman RL. Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer. Gynecol Oncol 2005; 97: 10-15.   DOI   ScienceOn
6 Greene JA, Richardson RC, Thornhill JA. Ovarian papillary cystadenocarcinoma in a bitch: case report and literature review. J Am Anim Hosp Assoc 1979; 15: 351-6.
7 Hayes A, Harvey HJ. Treatment of metastatic granulosa cell tumor in a dog. J Am Vet Med Assoc 1979; 174: 1304-6.
8 Lagrasse LD, Peretorius RG. The metabolism of cisdichlorodiammineplatinum, distribution, clearance, and toxicity. Am J Obstet Gynecol 1981; 139: 791-796.   DOI
9 Lesnock JL, Richard SD, Zorn KK, Krivak TC, Beriwal S, Sukumvanich P, et al. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications. Gynecol Oncol 2010; 116: 345-350.   DOI   ScienceOn
10 Los G, Verdegaal EM, Mutsaers PH, McVie JG. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol. 1991; 28: 159-165.   DOI   ScienceOn
11 Markman M, Blessing JA, Major F, Manetta A. Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study. Gynecol Oncol 1993; 50: 191-195.   DOI   ScienceOn
12 Moore AS, Kirk C, Cardona A. Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 1991; 5: 227-231.   DOI
13 Neijt JP. Ovarian cancer treatment: time for some hard thinking. Eur J Cancer 1991; 27: 680-681.   DOI
14 Nielsen SW. Classification of tumors in dogs and cats. J Am Anim Hosp Assoc 1983; 19: 13-52.
15 Nielsen SW, Misdorp W, McEntee K. Tumours of the ovary. Bull World Health Organ 1976; 53: 203-215.
16 Bonagura, J. Medical and surgical management of pleural effusion. In: Kirk's Current Veterinary Therapy: XIII Small Animal Practice. Philadelphia: WB Saunders. 2000: 819-825.
17 Olsen J, Komtebedde J, Lackner A, Madewell BR. Cytoreductive treatment of ovarian carcinoma in a dog. J Vet Intern Med 1994; 8: 133-135.   DOI   ScienceOn
18 Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 34-43.   DOI   ScienceOn
19 Barber HR. New frontiers in ovarian cancer diagnosis and management. Yale J Biol Med. 1991; 64: 127-141.
20 Cotchin E. Testicular neoplasms in dogs. J Comp Pathol 1960; 70: 232-248.   DOI
21 Dow C. Ovarian abnormalities in the bitch. J Comp Pathol 1960; 70: 59-69.   DOI
22 Esposito M, Campora E, Repetto M, Fulco RA, Simoni GA, Falcone A, et al. Regional pharmacokinetic selectivity of intraperitoneal cisplatin in ovarian cancer. Oncology 1988; 45: 69-73.   DOI   ScienceOn
23 Echarri Gonzalez MJ, Green R, Muggia FM. Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when? Oncology 2011; 25: 156-165, 70.